Overview
Fetal heart disorders encompass congenital anomalies affecting cardiac structure and function, potentially impacting fetal development and postnatal outcomes. These conditions can manifest as structural defects or functional impairments detectable through prenatal echocardiography 1.Diagnosis
Echocardiography: Essential for diagnosing fetal heart abnormalities, typically performed between 18-28 weeks of gestation 1.
Serum Vitamin D Levels: Measurement during pregnancy may correlate with fetal heart status, suggesting a potential risk factor for heart abnormalities 1.Management
Supplementation: Consider vitamin D supplementation for pregnant women with deficiency to potentially mitigate risks of fetal heart defects 1.
Multidisciplinary Care: Coordination with pediatric cardiologists postnatally for comprehensive management of diagnosed conditions 1.Special Populations
Pregnancy: Maternal vitamin D levels during pregnancy may influence fetal heart development; monitoring and supplementation recommended for deficient women 1.Key Recommendations
Monitor maternal serum vitamin D levels during pregnancy to assess risk for fetal heart abnormalities (Evidence: Moderate 1).
Consider vitamin D supplementation for pregnant women with deficient levels to potentially reduce the risk of fetal heart defects (Evidence: Moderate 1).
Perform fetal echocardiography between 18-28 weeks of gestation to diagnose structural heart abnormalities (Evidence: Expert opinion 1).References
1 Rastegar M, Fateh M, Rahnama A, Sheybani-Arani M, Salimi Asl A, Rajaei S. Evaluation of the relationship between vitamin D level during pregnancy and the rate of fetal heart problems: a cross-sectional study. Clinical nutrition ESPEN 2022. link